Update: Duke filed an application to increase its distribution rates, seeking a $15.4 million increase in revenue. Staff, however, filed its report and recommended a revenue decrease between $18.4 million and $28.9 million. 

Staff also recommended that the Commission deny Duke’s request to extend its Delivery Capital Investment (DCI) Rider indefinitely to general, intangible, and common plant, and limit the DCI Rider term to May 31, 2024 if Duke files another rate case by May 31, 2023. Finally, Staff recommended caps on revenue from the DCI Rider for 2018 through 2024.

Objections to the Staff Report and expert testimony are due on October 26, 2017. The evidentiary hearing begins on December 11, 2017.